Post job

Obalon Therapeutics CEO and executives

Executive Summary. Based on our data team's research, William J. Plovanic is the Obalon Therapeutics's CEO. Obalon Therapeutics has 100 employees, of which 6 are in a leadership position.
Work at Obalon Therapeutics?
Share your experience

Rate Obalon Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
William J. Plovanic

President and Chief Executive Officer

Andy Rasdal

Founder

Andy Rasdal's LinkedIn

More than 25 years of medical technology experience, including serving as CEO of DexCom, Inc., Senior Vice President and President Vascular for Medtronic, Inc., and Vice President of Marketing for Arterial Vascular Engineering.

Mark Brister

CTO

Mark Brister's LinkedIn

Nooshin Hussainy

Chief Financial Officer

Nooshin Hussainy's LinkedIn

Ms. Hussainy is a Chief Financial Officer at Obalon Therapeutics, Inc. He joined Obalon in November 2011. She has over 20 years of experience in high growth companies ranging from Fortune 100 to venture-backed start-ups. She completed 2 IPOs in medical devices and diagnostics, secondary offerings, and debt offerings. Most recently she served as the Vice President of Accounting at GenMark Diagnostics.

Amy Vandenberg

Chief Quality Assurance, Clinical & Regulatory Affairs Officer

Kim Kamdar

Board Member

Do you work at Obalon Therapeutics?

Does leadership effectively guide Obalon Therapeutics toward its goals?

Obalon Therapeutics jobs

Obalon Therapeutics founders

Name & TitleBio
Andy Rasdal

Founder

Andy Rasdal's LinkedIn

More than 25 years of medical technology experience, including serving as CEO of DexCom, Inc., Senior Vice President and President Vascular for Medtronic, Inc., and Vice President of Marketing for Arterial Vascular Engineering.

Obalon Therapeutics board members

Name & TitleBio
William J. Plovanic

President and Chief Executive Officer

Andy Rasdal

Founder

Andy Rasdal's LinkedIn

More than 25 years of medical technology experience, including serving as CEO of DexCom, Inc., Senior Vice President and President Vascular for Medtronic, Inc., and Vice President of Marketing for Arterial Vascular Engineering.

Kim Kamdar

Board Member

Obalon Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Obalon Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Obalon Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Obalon Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Obalon Therapeutics. The data presented on this page does not represent the view of Obalon Therapeutics and its employees or that of Zippia.

Obalon Therapeutics may also be known as or be related to OBALON THERAPEUTICS INC, Obalon Therapeutics, Obalon Therapeutics Inc and Obalon Therapeutics, Inc.